Biocytogen Announces Licensing of Fully Human Antibodies with SOTIO to Develop Novel ADC SOT109 for Colorectal Cancer Treatment ...

Alloy Therapeutics ("Alloy"), a biotechnology ecosystem company dedicated to democratizing access to cutting edge drug ...

HALIFAX, NS / ACCESSWIRE / / Today, MedMira Inc. (MedMira) (TSXV:MIR) announced that its received investigational testing ...

Samsung Biologics has extended its collaboration with LigaChem Biosciences for antibody-drug conjugate (ADC) services. The ...

BEIJING & ALAMEDA, Calif. & TAIPEI — Biocytogen (HKEX: 02315) and Acepodia (6976:TT), today announced a groundbreaking ...

WUXI BIO (02269.HK) announced that it had inked a research service collaboration agreement with Candid Therapeutics. Under ...

Monoclonal Antibodies IndustryThe global monoclonal antibodies (mAbs) industry, valued at USD 186 billion in 2021, is ...

I-Mab said it has paused the development of uliledlimab to focus on a Phase I trial of its lead candidate givastomig.

Under the terms of the license agreement, Immunome will be responsible for the research, development, manufacturing and ...

Biocytogen (HKEX: 02315), a global biotech company dedicated to discovering and developing novel antibody therapeutics, announced the licensing of its ...

PD-1 x VEGF antibodies show potential to surpass checkpoint inhibitors as standard-of-care in multiple oncology indications• NAYA aiming to ...

Shares of Fusion Antibodies plc (LON:FAB – Get Free Report) reached a new 52-week high on Friday . The company traded as high as GBX 10.25 ($0.13) and last traded at GBX 10.23 ($0.13), with a volume ...